Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction.

Fujisue K, Tokitsu T, Yamamoto E, Sueta D, Takae M, Nishihara T, Oike F, Usuku H, Ito M, Motozato K, Kanazawa H, Araki S, Arima Y, Takashio S, Izumiya Y, Suzuki S, Sakamoto K, Kaikita K, Tsujita K.

Medicine (Baltimore). 2019 Jul;98(28):e15959. doi: 10.1097/MD.0000000000015959.

2.

Prognostic value of high-sensitive troponin T for predicting cardiovascular events after atrial fibrillation ablation.

Tamura S, Doi A, Matsuo M, Katayama H, Yoshiyama T, Tatsumi H, Izumiya Y, Yoshiyama M.

J Cardiovasc Electrophysiol. 2019 Jun 13. doi: 10.1111/jce.14032. [Epub ahead of print]

PMID:
31192482
3.

Combination of Commonly Examined Parameters Is a Useful Predictor of Positive 99 mTc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.

Marume K, Takashio S, Nishi M, Hirakawa K, Yamamoto M, Hanatani S, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Sakamoto K, Yamamoto E, Kaikita K, Izumiya Y, Yamashita Y, Ando Y, Tsujita K.

Circ J. 2019 Jun 13. doi: 10.1253/circj.CJ-19-0255. [Epub ahead of print]

4.

An autopsy case of anaplastic lymphoma kinase-positive lung cancer exacerbated in a short period of time: a case report.

Takeda M, Sato K, Sakamoto S, Suzuki M, Izumiya Y, Kumagai N, Sudo K, Okuda Y, Asano M, Sano M, Omori Y, Nakayama K.

J Med Case Rep. 2019 Apr 29;13(1):118. doi: 10.1186/s13256-019-2054-3.

5.

Association between debulking area of rotational atherectomy and platform revolution speed-Frequency domain optical coherence tomography analysis.

Mizutani K, Hara M, Nakao K, Yamaguchi T, Okai T, Nomoto Y, Kajio K, Kaneno Y, Yamazaki T, Ehara S, Kamimori K, Izumiya Y, Yoshiyama M.

Catheter Cardiovasc Interv. 2019 Apr 11. doi: 10.1002/ccd.28212. [Epub ahead of print]

PMID:
30977274
6.

HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways.

Zhou F, Liu X, Gao L, Zhou X, Cao Q, Niu L, Wang J, Zuo D, Li X, Yang Y, Hu M, Yu Y, Tang R, Lee BH, Choi BW, Wang Y, Izumiya Y, Xue M, Zheng K, Gao D.

J Neuroinflammation. 2019 Apr 4;16(1):71. doi: 10.1186/s12974-019-1466-8.

7.

Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.

Kivelä R, Hemanthakumar KA, Vaparanta K, Robciuc M, Izumiya Y, Kidoya H, Takakura N, Peng X, Sawyer DB, Elenius K, Walsh K, Alitalo K.

Circulation. 2019 May 28;139(22):2570-2584. doi: 10.1161/CIRCULATIONAHA.118.036099. Epub 2019 Mar 29.

PMID:
30922063
8.

A retrospective study of arterial stiffness and subsequent clinical outcomes in cancer patients undergoing percutaneous coronary intervention.

Tabata N, Sueta D, Yamamoto E, Takashio S, Arima Y, Araki S, Yamanaga K, Ishii M, Sakamoto K, Kanazawa H, Fujisue K, Hanatani S, Soejima H, Hokimoto S, Izumiya Y, Kojima S, Yamabe H, Kaikita K, Matsui K, Tsujita K.

J Hypertens. 2019 Apr;37(4):754-764. doi: 10.1097/HJH.0000000000001949.

PMID:
30817457
9.

Self-expandable transcatheter aortic valve replacement is associated with frequent periprocedural stroke detected by diffusion-weighted magnetic resonance imaging.

Kajio K, Mizutani K, Hara M, Nakao M, Okai T, Ito A, Takahashi Y, Iwata S, Shimono T, Izumiya Y, Murakami T, Shibata T, Yoshiyama M.

J Cardiol. 2019 Jul;74(1):27-33. doi: 10.1016/j.jjcc.2019.01.013. Epub 2019 Feb 20.

PMID:
30795938
10.

Blepharoptosis due to Sarcoidosis-induced Horner Syndrome.

Takeda M, Sato K, Sano M, Sakamoto S, Izumiya Y, Kumagai N, Sudo K, Asano M, Okuda Y, Nakayama K.

Am J Respir Crit Care Med. 2019 Jul 1;200(1):101-102. doi: 10.1164/rccm.201807-1285IM. No abstract available.

PMID:
30789746
11.

A retrospective study of arterial stiffness and subsequent clinical outcomes in cancer patients undergoing percutaneous coronary intervention.

Tabata N, Sueta D, Yamamoto E, Takashio S, Arima Y, Araki S, Yamanaga K, Ishii M, Sakamoto K, Kanazawa H, Fujisue K, Hanatani S, Soejima H, Hokimoto S, Izumiya Y, Kojima S, Yamabe H, Kaikita K, Matsui K, Tsujita K.

J Hypertens. 2019 Jan 7. doi: 10.1097/HJH.0000000000001949. [Epub ahead of print]

PMID:
30624366
12.

An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.

Ieda N, Itoh K, Inoue Y, Izumiya Y, Kawaguchi M, Miyata N, Nakagawa H.

Bioorg Med Chem Lett. 2019 Feb 1;29(3):353-356. doi: 10.1016/j.bmcl.2018.12.044. Epub 2018 Dec 19.

PMID:
30585173
13.

Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation.

Shirahama R, Ono T, Nagamatsu S, Sueta D, Takashio S, Chitose T, Fujisue K, Sakamoto K, Yamamoto E, Izumiya Y, Kaikita K, Hokimoto S, Hori M, Harada-Shiba M, Kajiwara I, Ogawa H, Tsujita K.

Intern Med. 2018;57(24):3551-3557. doi: 10.2169/internalmedicine.1060-18. Epub 2018 Dec 15.

14.

Greater Nocturnal Blood Pressure Is Associated With Natriuretic Peptide Level in Aortic Stenosis With Preserved Ejection Fraction.

Tamura S, Iwata S, Ito A, Ishikawa S, Mizutani K, Izumiya Y, Yamada T, Murakami T, Shibata T, Yoshiyama M.

Circ J. 2019 Jan 25;83(2):447-451. doi: 10.1253/circj.CJ-18-0818. Epub 2018 Nov 22.

15.

Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis.

Pavasini R, Serenelli M, Celis-Morales CA, Gray SR, Izawa KP, Watanabe S, Colin-Ramirez E, Castillo-Martínez L, Izumiya Y, Hanatani S, Onoue Y, Tsujita K, Macdonald PS, Jha SR, Roger VL, Manemann SM, Sanchis J, Ruiz V, Bugani G, Tonet E, Ferrari R, Volpato S, Campo G.

Heart. 2019 Jun;105(11):834-841. doi: 10.1136/heartjnl-2018-313816. Epub 2018 Nov 19.

PMID:
30455175
16.

Myocardial Ischemia Suppresses Ketone Body Utilization.

Arima Y, Izumiya Y, Ishida T, Takashio S, Ishii M, Sueta D, Fujisue K, Sakamoto K, Kaikita K, Tsujita K.

J Am Coll Cardiol. 2019 Jan 22;73(2):246-247. doi: 10.1016/j.jacc.2018.10.040. Epub 2018 Nov 5. No abstract available.

PMID:
30408507
17.

HIV-1 Nef-induced lncRNA AK006025 regulates CXCL9/10/11 cluster gene expression in astrocytes through interaction with CBP/P300.

Zhou F, Liu X, Zuo D, Xue M, Gao L, Yang Y, Wang J, Niu L, Cao Q, Li X, Hua H, Zhang B, Hu M, Gao D, Zheng K, Izumiya Y, Tang R.

J Neuroinflammation. 2018 Oct 31;15(1):303. doi: 10.1186/s12974-018-1343-x.

18.

Clinical usefulness of dobutamine stress echocardiography for the assessment of double-chambered right ventricle.

Ito A, Iwata S, Ehara S, Izumiya Y, Yoshiyama M.

Eur Heart J Cardiovasc Imaging. 2019 Jan 1;20(1):120. doi: 10.1093/ehjci/jey158. No abstract available.

PMID:
30376065
19.

Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.

Hirakawa K, Takashio S, Marume K, Yamamoto M, Hanatani S, Yamamoto E, Sakamoto K, Izumiya Y, Kaikita K, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Yamashita Y, Ando Y, Tsujita K.

ESC Heart Fail. 2019 Feb;6(1):122-130. doi: 10.1002/ehf2.12361. Epub 2018 Oct 4.

20.

Novel assessment of retrospective on-demand analysis of venous thromboembolism by dual-layer spectral-detector CT.

Sueta D, Utsunomiya D, Izumiya Y, Nakaura T, Oda S, Kaikita K, Yamashita Y, Tsujita K.

J Cardiol Cases. 2018 May 31;18(3):88-91. doi: 10.1016/j.jccase.2018.05.003. eCollection 2018 Sep.

21.

Coronary blood flow volume change is negatively associated with platelet aggregability in patients with non-obstructive ischemic heart disease who have no anti-platelet agents.

Takae M, Yamamoto E, Fujisue K, Oike F, Nishihara T, Sueta D, Usuku H, Motozato K, Ito M, Hanatani S, Kanazawa H, Arima Y, Takashio S, Nakamura T, Suzuki S, Sakamoto K, Izumiya Y, Soejima H, Kojima S, Yamabe H, Kaikita K, Tsujita K.

Int J Cardiol. 2019 Feb 15;277:3-7. doi: 10.1016/j.ijcard.2018.08.068. Epub 2018 Aug 24.

PMID:
30173925
22.

Akt1-Mediated Muscle Growth Promotes Blood Flow Recovery After Hindlimb Ischemia by Enhancing Heme Oxygenase-1 in Neighboring Cells.

Onoue Y, Izumiya Y, Hanatani S, Ishida T, Arima Y, Yamamura S, Kimura Y, Araki S, Ishii M, Nakamura T, Oimatsu Y, Sakamoto K, Yamamoto E, Kojima S, Kaikita K, Tsujita K.

Circ J. 2018 Oct 25;82(11):2905-2912. doi: 10.1253/circj.CJ-18-0135. Epub 2018 Aug 10.

23.

KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC.

Wang HJ, Pochampalli M, Wang LY, Zou JX, Li PS, Hsu SC, Wang BJ, Huang SH, Yang P, Yang JC, Chu CY, Hsieh CL, Sung SY, Li CF, Tepper CG, Ann DK, Gao AC, Evans CP, Izumiya Y, Chuu CP, Wang WC, Chen HW, Kung HJ.

Oncogene. 2019 Jan;38(1):17-32. doi: 10.1038/s41388-018-0414-x. Epub 2018 Aug 2.

PMID:
30072740
24.

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.

Ishii M, Kaikita K, Sato K, Sueta D, Fujisue K, Arima Y, Oimatsu Y, Mitsuse T, Onoue Y, Araki S, Yamamuro M, Nakamura T, Izumiya Y, Yamamoto E, Kojima S, Kim-Mitsuyama S, Ogawa H, Tsujita K.

JACC Basic Transl Sci. 2017 Dec 25;2(6):655-668. doi: 10.1016/j.jacbts.2017.08.001. eCollection 2017 Dec.

25.

Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients.

Nishihara T, Tokitsu T, Sueta D, Takae M, Oike F, Fujisue K, Usuku H, Takashio S, Hanatani S, Kanazawa H, Arima Y, Sakamoto K, Izumiya Y, Yamabe H, Kaikita K, Yamamoto E, Tsujita K.

Am J Hypertens. 2018 Sep 11;31(10):1098-1105. doi: 10.1093/ajh/hpy101.

PMID:
29985986
26.

Fetal Origins of Hypertension.

Arima Y, Nishiyama K, Izumiya Y, Kaikita K, Hokimoto S, Tsujita K.

Adv Exp Med Biol. 2018;1012:41-48. doi: 10.1007/978-981-10-5526-3_5. Review.

PMID:
29956193
27.

Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.

Ito M, Yamabe H, Koyama J, Kanazawa H, Kaneko S, Kanemaru Y, Kiyama T, Arima Y, Takashio S, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Shono T, Utsunomiya D, Sasaki Y, Yamashita Y, Tsujita K.

J Cardiol. 2018 Dec;72(6):480-487. doi: 10.1016/j.jjcc.2018.05.009. Epub 2018 Jun 21.

PMID:
29935765
28.

Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease - Sub-analysis of PRECISE-IVUS trial.

Fujisue K, Nagamatsu S, Shimomura H, Yamashita T, Nakao K, Nakamura S, Ishihara M, Matsui K, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Sakamoto K, Izumiya Y, Kaikita K, Hokimoto S, Ogawa H, Tsujita K.

Int J Cardiol. 2018 Oct 1;268:23-26. doi: 10.1016/j.ijcard.2018.04.051. Epub 2018 Jun 18.

PMID:
29925472
29.

Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction - The CALDERA-GENE Study.

Kaikita K, Yoshimura H, Ishii M, Kudoh T, Yamada Y, Yamamoto E, Izumiya Y, Kojima S, Shimomura H, Tsunoda R, Matsui K, Ogawa H, Tsujita K; CALDERA-GENE Investigators.

Circ J. 2018 May 25;82(6):1517-1525. doi: 10.1253/circj.CJ-18-0197. Epub 2018 May 8.

30.

Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases - INVITATION trial.

Fujisue K, Shirakawa T, Nakamura S, Yamamoto N, Oshima S, Matsumura T, Tsunoda R, Hirai N, Tayama S, Nakamura N, Hirose T, Maruyama H, Fujimoto K, Kajiwara I, Sakamoto T, Nakao K, Sakaino N, Hokimoto S, Nagayoshi Y, Hokamaki J, Shimomura H, Sakamoto K, Yamamoto E, Izumiya Y, Kaikita K, Ogawa H, Tsujita K; INVITATION study investigators.

J Cardiol. 2018 Oct;72(4):350-355. doi: 10.1016/j.jjcc.2018.03.012. Epub 2018 May 4.

PMID:
29735336
31.

Comprehensive assessment of takotsubo cardiomyopathy by cardiac computed tomography.

Sueta D, Oda S, Izumiya Y, Kaikita K, Kidoh M, Utsunomiya D, Yamashita Y, Tsujita K.

Emerg Radiol. 2019 Feb;26(1):109-112. doi: 10.1007/s10140-018-1610-2. Epub 2018 May 7.

PMID:
29732519
32.

[A Distal Bile Duct Carcinoma Patient Who Underwent Surgical Resection for Liver Metastasis].

Komiyama S, Izumiya Y, Kimura Y, Nakashima S, Kin S, Kawakami S.

Gan To Kagaku Ryoho. 2018 Mar;45(3):560-562. Review. Japanese.

PMID:
29650938
33.

Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease.

Hanatani S, Izumiya Y, Onoue Y, Tanaka T, Yamamoto M, Ishida T, Yamamura S, Kimura Y, Araki S, Arima Y, Nakamura T, Fujisue K, Takashio S, Sueta D, Sakamoto K, Yamamoto E, Kojima S, Kaikita K, Tsujita K.

Int J Cardiol. 2018 Oct 1;268:216-221. doi: 10.1016/j.ijcard.2018.03.064. Epub 2018 Apr 9.

PMID:
29650344
34.

Impact of Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions (from the Japanese Multicenter Registry).

Naganuma T, Tsujita K, Mitomo S, Ishiguro H, Basavarajaiah S, Sato K, Kobayashi T, Obata J, Nagamatsu S, Yamanaga K, Komura N, Sakamoto K, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Ogawa H, Nakamura S.

Am J Cardiol. 2018 Jun 15;121(12):1519-1523. doi: 10.1016/j.amjcard.2018.02.032. Epub 2018 Mar 13.

PMID:
29627112
35.

Evaluation of Collateral Source Characteristics With 3-Dimensional Analysis Using Micro-X-Ray Computed Tomography.

Arima Y, Hokimoto S, Tabata N, Nakagawa O, Oshima A, Matsumoto Y, Sato T, Mukunoki T, Otani J, Ishii M, Uchikawa M, Yamamoto E, Izumiya Y, Kaikita K, Ogawa H, Nishiyama K, Tsujita K.

J Am Heart Assoc. 2018 Mar 23;7(6). pii: e007800. doi: 10.1161/JAHA.117.007800.

36.

Reply to letter to the editor: "A simple sarcopenia screening test predicts future adverse events in patients with heart failure".

Izumiya Y, Hanatani S, Onoue Y, Tsujita K.

Int J Cardiol. 2018 Apr 1;256:28. doi: 10.1016/j.ijcard.2017.12.082. No abstract available.

PMID:
29454408
37.

Clinical Usefulness of Dual-Energy Cardiac Computed Tomography in Acute Coronary Syndrome Using a Dual-Layer Spectral Detector Scanner.

Nishihara T, Oda S, Sueta D, Izumiya Y, Kaikita K, Tsujita K, Utsunomiya D, Nakaura T, Yamashita Y.

Circ Cardiovasc Imaging. 2018 Feb;11(2):e007277. doi: 10.1161/CIRCIMAGING.117.007277. No abstract available.

PMID:
29444811
38.

Functional Imaging of Viral Transcription Factories Using 3D Fluorescence Microscopy.

Chen CP, Chuang F, Izumiya Y.

J Vis Exp. 2018 Jan 18;(131). doi: 10.3791/56832.

39.

[A Case of Laparoscopic-Endoscopic Cooperative Surgery for Duodenal Neuroendocrine Tumor(NET G1)].

Nakashima S, Hikami S, Izumiya Y, Tsuji T, Komiyama S, Sai S, Kawakami S.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1865-1867. Japanese.

PMID:
29394802
40.

Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner.

Oda S, Nakaura T, Utsunomiya D, Hirakawa K, Takashio S, Izumiya Y, Tsujita K, Hata H, Ando Y, Yamashita Y.

Amyloid. 2018 Jun;25(2):137-138. doi: 10.1080/13506129.2018.1424625. Epub 2018 Jan 8. No abstract available.

PMID:
29308670
41.

KSHV episomes reveal dynamic chromatin loop formation with domain-specific gene regulation.

Campbell M, Watanabe T, Nakano K, Davis RR, Lyu Y, Tepper CG, Durbin-Johnson B, Fujimuro M, Izumiya Y.

Nat Commun. 2018 Jan 4;9(1):49. doi: 10.1038/s41467-017-02089-9.

42.

Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study.

Tabata N, Sueta D, Yamamoto E, Takashio S, Arima Y, Araki S, Yamanaga K, Ishii M, Sakamoto K, Kanazawa H, Fujisue K, Hanatani S, Soejima H, Hokimoto S, Izumiya Y, Kojima S, Yamabe H, Kaikita K, Tsujita K; KUMA study investigators.

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):290-300. doi: 10.1093/ehjqcco/qcx047.

PMID:
29211884
43.

Utility of Single-Photon Emission Computed Tomography/Computed Tomography Fusion Imaging With 99 mTc-Pyrophosphate Scintigraphy in the Assessment of Cardiac Transthyretin Amyloidosis.

Tsuda N, Shiraishi S, Oda S, Ogasawara K, Sakamoto F, Tomiguchi S, Fujisue K, Takashio S, Izumiya Y, Tsujita K, Ando Y, Yamashita Y.

Circ J. 2018 Jun 25;82(7):1970-1971. doi: 10.1253/circj.CJ-17-1111. Epub 2017 Dec 2. No abstract available.

44.

Recent advances in diagnosis and treatment of cardiac amyloidosis.

Izumiya Y, Takashio S, Oda S, Yamashita Y, Tsujita K.

J Cardiol. 2018 Feb;71(2):135-143. doi: 10.1016/j.jjcc.2017.10.003. Epub 2017 Nov 5. Review.

45.

Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.

Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, Ueda M, Yamashita T, Ishibashi-Ueda H, Yasuda S, Ogawa H, Ando Y, Anzai T, Tsujita K.

ESC Heart Fail. 2018 Feb;5(1):27-35. doi: 10.1002/ehf2.12203. Epub 2017 Sep 4.

46.

Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study.

Tabata N, Yamamoto E, Hokimoto S, Yamashita T, Sueta D, Takashio S, Arima Y, Izumiya Y, Kojima S, Kaikita K, Matsui K, Fujimoto K, Sakamoto K, Shimomura H, Tsunoda R, Hirose T, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Koide S, Sakamoto T, Nakao K, Oshima S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators.

J Am Heart Assoc. 2017 Aug 16;6(8). pii: e006355. doi: 10.1161/JAHA.117.006355.

47.

Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.

Zhou F, Shimoda M, Olney L, Lyu Y, Tran K, Jiang G, Nakano K, Davis RR, Tepper CG, Maverakis E, Campbell M, Li Y, Dandekar S, Izumiya Y.

Mol Cancer Ther. 2017 Nov;16(11):2627-2638. doi: 10.1158/1535-7163.MCT-17-0041. Epub 2017 Aug 28.

48.

ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Lyu Y, Nakano K, Davis RR, Tepper CG, Campbell M, Izumiya Y.

J Virol. 2017 Oct 13;91(21). pii: e00980-17. doi: 10.1128/JVI.00980-17. Print 2017 Nov 1.

49.

Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System.

Ishii M, Kaikita K, Ito M, Sueta D, Arima Y, Takashio S, Izumiya Y, Yamamoto E, Yamamuro M, Kojima S, Hokimoto S, Yamabe H, Ogawa H, Tsujita K.

Sci Rep. 2017 Aug 7;7(1):7399. doi: 10.1038/s41598-017-07939-6.

50.

When Is the Optimal Timing of Surgical Intervention for Severe Functional Tricuspid Regurgitation?

Nakanishi N, Ishii M, Kaikita K, Okamoto K, Izumiya Y, Yamamoto E, Takashio S, Hokimoto S, Fukui T, Tsujita K.

Case Rep Cardiol. 2017;2017:9232658. doi: 10.1155/2017/9232658. Epub 2017 Jun 19.

Supplemental Content

Loading ...
Support Center